• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Marcela G. del Carmen, MD


  • Diver E, O'Connor O, Garrett L, Boruta D, Goodman A, Del Carmen M, Schorge J, Mueller P, Growdon W.Modest benefit of total parenteral nutrition and chemotherapy after venting gastrostomy tube placement.Gynecol Oncol. 2013 May;129(2):332-5.
  • Jeudin P, Liveright E, Del Carmen MG, Perkins RB.Race, ethnicity and income as factors for HPV vaccine acceptance and use.Hum Vaccin Immunother. 2013 Apr 9;9(7).
  • Rauh-Hain JA, Nitschmann CC, Worley MJ, Bradford LS, Berkowitz RS, Schorge JO, Campos SM, Del Carmen MG, Horowitz NS.Platinum resistance after neoadjuvant chemotherapy compared to primary surgery in patients with advanced epithelial ovarian carcinoma.Gynecol Oncol. 2013 Apr;129(1):63-8.
  • del Carmen MG, Avila-Wallace M.Effect of health care disparities on screening.Clin Obstet Gynecol. 2013 Mar;56(1):65-75.
  • Foley OW, Rauh-Hain JA, del Carmen MG.The role of intraoperative radiation therapy in the management of recurrent and locally advanced gynecologic cancers.Int J Gynecol Cancer. 2013 Jan;23(1):9-15.
  • Del Carmen MG, Birrer M, Schorge JO.Uterine papillary serous cancer: A review of the literature.Gynecol Oncol. 2012 Dec;127(3):651-61.
  • del Carmen MG, Micha J, Small L, Street DG, Londhe A, McGowan T.A phase II clinical trial of pegylated liposomal doxorubicin and carboplatin plus bevacizumab in patients with platinum-sensitive recurrent ovarian, fallopian tube, or primary peritoneal cancer.Gynecol Oncol. 2012 Sep;126(3):369-74.
  • Diver EJ, Rauh-Hain JA, Del Carmen MG.Total pelvic exenteration for gynecologic malignancies.Int J Surg Oncol. 2012;2012:693535.
  • Rauh-Hain JA, Growdon WB, Rodriguez N, Goodman AK, Boruta DM, Schorge JO, Horowitz NS, Del Carmen MG.Carcinosarcoma of the ovary: A case-control study.Gynecol Oncol. 2011 Mar 18.
  • McCann CK, Growdon WB, Munro EG, Del Carmen MG, Boruta DM, Schorge JO, Goodman A.Prognostic Significance of Splenectomy as Part of Initial Cytoreductive Surgery in Ovarian Cancer.Ann Surg Oncol. 2011 Mar 22.
  • Schorge JO, McCann C, Del Carmen MG.Surgical debulking of ovarian cancer: what difference does it make?.Rev Obstet Gynecol. 2010;3(3):111-7.
  • Rauh-Hain JA, Growdon WB, Schorge JO, Goodman AK, Boruta DM, McCann C, Horowitz NS, del Carmen MG.Prognostic determinants in patients with stage IIIC and IV uterine papillary serous carcinoma.Gynecol Oncol. 2010 Nov;119(2):299-304.
  • Allen JD, Othus MK, Shelton RC, Li Y, Norman N, Tom L, del Carmen MG.Parental decision making about the HPV vaccine.Cancer Epidemiol Biomarkers Prev. 2010 Sep;19(9):2187-98.
  • Rauh-Hain JA, Del Carmen MG.Treatment for advanced and recurrent endometrial carcinoma: combined modalities.Oncologist. 2010;15(8):852-61.
  • Chapman E, Venkat P, Ko E, Orezzoli JP, Del Carmen M, Garner EI.Use of multimedia as an educational tool to improve human papillomavirus vaccine acceptability-A pilot study.Gynecol Oncol. 2010 Aug 1;118(2):103-7.
  • Rauh-Hain JA, Olawaiye AB, Munro M, Ko E, Alarcon IA, Del Carmen MG, Duska L.Role of computed tomography in the surgical management of patients with bowel obstruction secondary to recurrent ovarian carcinoma.Ann Surg Oncol. 2010 Mar;17(3):853-60.
  • Alejandro Rauh-Hain J, Olawaiye AB, Munro EG, Ko E, Alarcon IA, Del Carmen MG, Duska L.Role of Computed Tomography in the Surgical Management of Patients with Bowel Obstruction Secondary to Recurrent Ovarian Carcinoma.Ann Surg Oncol. 2009 Nov 18.
  • Na YJ, Farley J, Zeh A, del Carmen M, Penson R, Birrer MJ.Ovarian cancer: markers of response.Int J Gynecol Cancer. 2009 Dec;19 Suppl 2:S21-9. Review.
  • Watts L, Joseph N, Velazquez A, Gonzalez M, Munro E, Muzikansky A, Rauh-Hain JA, Del Carmen MG.Understanding barriers to cervical cancer screening among Hispanic women.Am J Obstet Gynecol. 2009 Aug;201(2):199.e1-8.
  • Orezzoli JP,Sioletic S,Olawaiye A,Oliva E,del Carmen MG.Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion.Gynecol Oncol. 2009 Jun;113(3):316-23.
  • Goldstein MA,Goodman A,del Carmen MG,Wilbur DC.Case records of the Massachusetts General Hospital. Case 10-2009. A 23-year-old woman with an abnormal Papanicolaou smear.N Engl J Med. 2009 Mar 26;360(13):1337-44.
  • Pandharipande PV,Choy G,del Carmen MG,Gazelle GS,Russell AH,Lee SI.MRI and PET/CT for triaging stage IB clinically operable cervical cancer to appropriate therapy: decision analysis to assess patient outcomes.AJR Am J Roentgenol. 2009 Mar;192(3):802-14.
  • Watts LA,Joseph N,Wallace M,Rauh-Hain JA,Muzikansky A,Growdon WB,del Carmen MG.HPV vaccine: A comparison of attitudes and behavioral perspectives between Latino and non-Latino women.Gynecol Oncol. 2009 Mar;112(3):577-82.
  • Olawaiye AB,Rauh-Hain JA,Withiam-Leitch M,Rueda B,Goodman A,del Carmen MG.Utility of pre-operative serum CA-125 in the management of uterine papillary serous carcinoma.Gynecol Oncol. 2008 Sep;110(3):293-8.
  • del Carmen, MG.Primary squamous carcinoma of the uterine cervix: Diagnosis and management.Harrison's Manual of Oncology (Bruce A. Chabner, Dan L. Longo, Thomas J. Lynch Eds)..
  • del Carmen MG, Halpern EF, Kopans DB, Moy B, Moore RH, Goss PE, Hughes KS.Mammographic breast density and race.AJR Am J Roentgenol. 2007 Apr;188(4):1147-50.
  • del Carmen MG, Findley M, Muzikansky A, Roche M, Verrill CL, Horowitz N, Seiden MV.Demographic, risk factor, and knowledge differences between Latinas and non-Latinas referred to colposcopy.Gynecol Oncol. 2007 Jan;104(1):70-6.
  • Colantonio SE, Fuster V, Del Carmen M, Lascano JG.Isonymic relationships in ethno-social categories (Argentinian colonial period) including illegitimate reproduction.J Biosoc Sci. 2006 May;38(3):381-9.
  • del Carmen MG, Rizvi I, Chang Y, Moor AC, Oliva E, Sherwood M, Pogue B, Hasan T.Synergism of epidermal growth factor receptor-targeted immunotherapy with photodynamic treatment of ovarian cancer in vivo.J Natl Cancer Inst. 2005 Oct 19;97(20):1516-24.
  • del Carmen MG, Joffe S.Informed consent for medical treatment and research: a review.Oncologist. 2005 Sep;10(8):636-41.
  • del Carmen MG, Fuller AF, Matulonis U, Horick NK, Goodman A, Duska LR, Penson R, Campos S, Roche M, Seiden MV.Phase II trial of anastrozole in women with asymptomatic müllerian cancer.Gynecol Oncol. 2003 Dec;91(3):596-602.
  • Del Carmen MG, Smith Sehdev AE, Fader AN, Zahurak ML, Richardson M, Fruehauf JP, Montz FJ, Bristow RE.Endometriosis-associated ovarian carcinoma: differential expression of vascular endothelial growth factor and estrogen/progesterone receptors.Cancer. 2003 Oct 15;98(8):1658-63.
  • del Carmen MG, Hughes KS, Halpern E, Rafferty E, Kopans D, Parisky YR, Sardi A, Esserman L, Rust S, Michaelson J.Racial differences in mammographic breast density.Cancer. 2003 Aug 1;98(3):590-6.
  • del Carmen MG, McIntyre JF, Fuller AF, Nikrui N, Goodman A.Intraoperative radiation therapy in the treatment of pelvic gynecologic malignancies: a review of fifteen cases.Gynecol Oncol. 2000 Dec;79(3):457-62.
  • del Carmen MG, Montz FJ, Bristow RE, Bovicelli A, Cornelison T, Trimble E.Ethnic differences in patterns of care of stage 1A(1) and stage 1A(2) cervical cancer: a SEER database study.Gynecol Oncol. 1999 Oct;75(1):113-7.